Rosacea is a common condition that usually starts as flushing and subtle redness on the cheeks, nose, chin or forehead. Alcohol, hot drinks, spicy foods, stress, sunlight, and extreme heat or cold can trigger the onset of this disease. If left untreated, rosacea can slowly worsen over time. As the condition progresses, patients can experience inflammatory lesions.
People with moderate to severe papulopustular rosacea (a.k.a. rosacea with inflammatory lesions) may be eligible to join this research study of an investigational medication for the condition. Eligible participants will receive compensation for study-related time as well as study-related exams at no cost.
- Must be age 18 or older
- Must have been diagnosed with moderate to severe rosacea (and have inflammatory lesions on the face)
- Will receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can also talk to a Meridian enrollment specialist about this study by calling (402) 934-7563.
Submit your information
Meridian Clinical Research
375 Glensprings Drive 2nd Flr
Cincinnati, OH 45246
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.